Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin (Q33739836)

29 July 2017

title

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin (English)

1 reference

29 July 2017

main subject

Pseudomonas aeruginosa

0 references

author name string

Blaser J

1

1 reference

29 July 2017

Dudley MN

2

1 reference

29 July 2017

Gilbert D

3

1 reference

29 July 2017

Zinner SH

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

29

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

927-929

1 reference

Method of reliable determination of minimal lethal antibiotic concentrations

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic Diluent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284183

Cephradine concentrations in serum, pleural fluid, pleura, and lung of normal rabbits

21 June 2018

1 reference

12 December 2020

1 reference

12 December 2020

Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin

1 reference

12 December 2020

Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: A comparative double-blind study

1 reference

12 December 2020

Reversal of the Antibacterial Activity of Polymyxin by Divalent Cations

1 reference

12 December 2020

The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity

1 reference

12 December 2020

Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.29.5.927

1 reference

29 July 2017

1 reference

29 July 2017

1 reference